IMR Press / JIN / Special Issues / affective_disorders

Progress in Affective Disorders

Submission deadline: 30 September 2022
Special Issue Editors
Trevor Archer, PhD
Department of Psychology, University of Gothenburg, Gothenburg, Sweden
Interests: neurotoxicity; neuropsychiatry; movement disorders; epigenetics; interventions
Special Issue Information

Dear Colleagues,

Affective disorders, including depression, mood and schizoaffective and anxiety episodes and inflammatory conditions present close associations with both behavioral and biological contiguity with possible reciprocal determination of each other in a bidirectional loop. Depressive states facilitate inflammatory reactions whereas inflammatory conditions promote depressive onset and continuance together other neuropsychiatric affective features. Patients presenting affective disorders demonstrate all the cardinal features of inflammation, such as increased circulating levels of inflammatory inducers, activated sensors, and inflammatory mediators targeting a plethora of brain and CNS and other tissues throughout the body of the afflicted individual. It is becoming increasingly evident that the etiopathophysiology and the clinical debut and progression of these disorders are promoted by a range of inflammatory processes originating both intrinsically and extrinsically. Notably, pro-inflammatory cytokines modulate mood behavior, motivation, cognitive functioning and somatic integrity through the reduction of brain monoamine and metabolic levels, the activation neuroendocrine responses, promotion excitotoxicity (increased glutamate levels), and the impairment of brain plasticity and memory. In this context, the contributions of early-life adversity and stress trauma seem to produce the underpinnings of epigenetic misadventure than maintain the dispositions of illhealth and negative prognoses. Under a variety of circumstance, physical exercise, by itself or combined with dietary implementation, has provided substantial levels of amelioration of the affective detriments.

Prof. Dr. Trevor Archer 

Guest Editor

Keywords
affect
inflammation
amelioration
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1900 USD. Submitted manuscripts should be well formatted in good English.

Back to top